Press-release for stocks related to bioscience

Prices are updated after-hours

tags : Bioscience crawled time : 12:00

save search

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -37.32% | O: 1.36% H: 0.68% C: -0.64%
ovaprene test positive bioscience publication contraceptive contraception study

Skye Bioscience Uplists to The Nasdaq Global Market
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
SKYE | $15.65 -7.78% 8.7K

Transportation and Warehousing

| 89.31% | O: 6.87% H: 44.87% C: 30.71%
nasdaq bioscience global market

Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -35.19% | O: 8.01% H: 0.0% C: -5.0%
conference company year bioscience update financial results

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Published: 2024-03-07 (Crawled : 12:00) - globenewswire.com
HBIO | $3.99 0.5% 35K

Health Technology

| -0.49% | O: -1.22% H: 13.42% C: 11.08%
bioscience financial results

Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
SKYE | $15.65 -7.78% 8.7K

Transportation and Warehousing

| 3.77% | O: 1.91% H: 13.84% C: 5.57%
bioscience

Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
SKYE | $15.65 -7.78% 8.7K

Transportation and Warehousing

| 141.11% | O: 6.66% H: 7.43% C: 6.72%
sbi-100 glaucoma ocular bioscience hypertension trial

Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
SKYE | $15.65 -7.78% 8.7K

Transportation and Warehousing

| 1020.0% | O: 3.23% H: 6.25% C: -3.13%
sbi-100 glaucoma bioscience study phase 2

Harvard Bioscience Announces Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
HBIO | $3.99 0.5% 35K

Health Technology

| -4.88% | O: -0.23% H: 4.9% C: -0.93%
bioscience financial results

Daré Bioscience Announces Additional Positive Data from Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women and Proposed Endpoints and Patient Population for Phase 3 Program
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -29.91% | O: 5.14% H: 0.0% C: -8.89%
positive bioscience women program study

INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
Published: 2023-10-23 (Crawled : 12:00) - invobioscience.com
INVO | $1.325 -12.83% 700K

Health Technology

| 40.74% | O: 174.07% H: 105.41% C: 43.24%
company life bioscience agreement

Daré Bioscience Announces Achievement of First Commercial Milestone Under License Agreement for XACIATO™ (Clindamycin Phosphate) Vaginal Gel, 2%, FDA-Approved Treatment for Bacterial Vaginosis in Females 12 Years or Older
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -34.78% | O: 7.39% H: 21.46% C: 6.44%
license bioscience treatment commercial agreement milestone

Daré Bioscience to Present at The Menopause Society 2023 Annual Meeting
Published: 2023-09-20 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -36.17% | O: 0.0% H: 2.77% C: -3.21%
bioscience meeting

Daré Bioscience to Participate in Upcoming Investor Conferences
Published: 2023-09-06 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -54.55% | O: 0.0% H: 0.59% C: -5.3%
bioscience

Daré Bioscience Completes Previously Announced Equity Financing
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -55.86% | O: 1.38% H: 1.6% C: -4.21%
bioscience

Daré Bioscience Announces $7.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-08-30 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -56.67% | O: -0.35% H: 2.9% C: 2.88%
nasdaq direct bioscience offering

Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
DAWN 4 | $15.45 -1.91% 140K

Professional, Scientific, and T...

| 6.02% | O: 0.87% H: 1.58% C: -3.24%
day license one bioscience research collaboration agreement

Daré Bioscience Reports Second Quarter 2023 Financial Results and Provides a Company Update
Published: 2023-08-10 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -59.01% | O: 1.11% H: 0.0% C: -3.36%
bioscience update financial results

Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a Phase 1/2 Clinical Trial of DARE-HRT1 Intravaginal Rings
Published: 2023-08-09 (Crawled : 12:00) - globenewswire.com
DARE | $0.2951 94K

Health Technology

| -58.33% | O: -2.18% H: 5.07% C: 3.92%
positive bioscience publication treatment trial

Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
Published: 2023-08-04 (Crawled : 12:00) - biospace.com/
TWST | News | $28.94 2.05% 110K

Health Technology